187 related articles for article (PubMed ID: 8938309)
1. Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine.
Ogawa T; Inugami A; Hatazawa J; Kanno I; Murakami M; Yasui N; Mineura K; Uemura K
AJNR Am J Neuroradiol; 1996 Feb; 17(2):345-53. PubMed ID: 8938309
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.
Chung JK; Kim YK; Kim SK; Lee YJ; Paek S; Yeo JS; Jeong JM; Lee DS; Jung HW; Lee MC
Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):176-82. PubMed ID: 11926379
[TBL] [Abstract][Full Text] [Related]
3. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors.
Ericson K; Lilja A; Bergström M; Collins VP; Eriksson L; Ehrin E; von Holst H; Lundqvist H; Långsrom B B; Mosskin M
J Comput Assist Tomogr; 1985; 9(4):683-9. PubMed ID: 3926834
[TBL] [Abstract][Full Text] [Related]
5. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K
Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862
[TBL] [Abstract][Full Text] [Related]
7. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
[TBL] [Abstract][Full Text] [Related]
8. C-11 methionine and F-18 FDG uptake in a patient with meningioma and glioblastoma multiforme.
Korkmaz M; Kim EE; Wong FC; Podoloff DA
Clin Nucl Med; 1996 Jul; 21(7):580-2. PubMed ID: 8818480
[No Abstract] [Full Text] [Related]
9. Radiation-induced meningioma evaluated with positron emission tomography with fludeoxyglucose F 18.
Kado H; Ogawa T; Hatazawa J; Iwase M; Kanno I; Okudera T; Uemura K
AJNR Am J Neuroradiol; 1996 May; 17(5):937-8. PubMed ID: 8733970
[TBL] [Abstract][Full Text] [Related]
10. Dynamic study of supratentorial gliomas with L-methyl-11C-methionine and positron emission tomography.
Lilja A; Bergström K; Hartvig P; Spännare B; Halldin C; Lundqvist H; Långstrom B
AJNR Am J Neuroradiol; 1985; 6(4):505-14. PubMed ID: 2992257
[TBL] [Abstract][Full Text] [Related]
11. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer.
Lindholm P; Leskinen-Kallio S; Minn H; Bergman J; Haaparanta M; Lehikoinen P; Någren K; Ruotsalainen U; Teräs M; Joensuu H
J Nucl Med; 1993 Oct; 34(10):1711-6. PubMed ID: 8410288
[TBL] [Abstract][Full Text] [Related]
12. 11C-Methionine Positron Emission Tomography/Computed Tomography Versus 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Evaluation of Residual or Recurrent World Health Organization Grades II and III Meningioma After Treatment.
Tomura N; Saginoya T; Goto H
J Comput Assist Tomogr; 2018; 42(4):517-521. PubMed ID: 29613985
[TBL] [Abstract][Full Text] [Related]
13. 11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds.
Voges J; Herholz K; Hölzer T; Würker M; Bauer B; Pietrzyk U; Treuer H; Schröder R; Sturm V; Heiss WD
Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):129-35. PubMed ID: 9711745
[TBL] [Abstract][Full Text] [Related]
14. Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography.
Utriainen M; Metsähonkala L; Salmi TT; Utriainen T; Kalimo H; Pihko H; Mäkipernaa A; Harila-Saari A; Jyrkkiö S; Laine J; Någren K; Minn H
Cancer; 2002 Sep; 95(6):1376-86. PubMed ID: 12216107
[TBL] [Abstract][Full Text] [Related]
15. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study.
Leskinen-Kallio S; Ruotsalainen U; Någren K; Teräs M; Joensuu H
J Nucl Med; 1991 Jun; 32(6):1211-8. PubMed ID: 2045935
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of
He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X
BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564
[TBL] [Abstract][Full Text] [Related]
17. 11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.
Hirata T; Kinoshita M; Tamari K; Seo Y; Suzuki O; Wakai N; Achiha T; Umehara T; Arita H; Kagawa N; Kanemura Y; Shimosegawa E; Hashimoto N; Hatazawa J; Kishima H; Teshima T; Ogawa K
J Neurosurg; 2019 Sep; 131(3):676-686. PubMed ID: 30239314
[TBL] [Abstract][Full Text] [Related]
18. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
[TBL] [Abstract][Full Text] [Related]
19. PET for diagnosis of malignant lymphoma of the scalp: comparison of [11C]methyl-L-methionine and [18F]fluoro-2-deoxyglucose.
Tsuyuguchi N; Hakuba A; Okamura T; Ochi H; Suzuki T; Sunada I
J Comput Assist Tomogr; 1997; 21(4):590-3. PubMed ID: 9216763
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of PET for the evaluation of brain tumors.
Coleman RE; Hoffman JM; Hanson MW; Sostman HD; Schold SC
J Nucl Med; 1991 Apr; 32(4):616-22. PubMed ID: 2013802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
